Controlled Substances Expertise Benuvia specializes in development and cGMP manufacturing of highly regulated compounds including cannabinoids and psychedelics, offering end-to-end solutions from formulation to packaging. This positions them as a strategic partner for firms seeking compliant, scale-ready production of controlled substances.

Strategic Partnerships Recent and ongoing collaborations with Mikart, Khona Scientific, Avernus Pharma, and Bright Green Corporation indicate a active partner ecosystem. This suggests opportunities to co-sell, cross-sell, or fuel joint development programs for regulated APIs and finished-dose products.

U.S. API Footprint With Round Rock, Texas as the sole U.S. API facility producing FDA approved cannabinoid drug, Benuvia offers localized, compliant manufacturing capabilities that can support domestic supply strategies and faster time-to-market for U.S.-based clients.

Full-Service CDMO Benuvia delivers end-to-end services across formulation, API synthesis, analytical development, serialization, labeling, warehousing, import/export, and regulatory affairs. This broad service suite enables one-stop sourcing for complex regulated programs, reducing vendor management complexity.

Regulatory Credibility DEA, FDA, EPA, and OSHA compliance, plus extensive experience in cannabinoids and psychedelics, enhances risk mitigation for clients pursuing regulated therapies. This credibility is a key differentiator for companies navigating regulatory pathways and market approvals.